Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “solution”

118 pharma patents match "solution" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 118
Index total 30,257
Page 3 / 5

Quick answer

This filtered view shows 118 pharmaceutical patents matching "solution" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

118 results for “solution” · 30,257 patents in full index Clear search

  1. US 10138466

    Compositions and methods for differentiating stem cells into cell populations comprising beta-like cells

    REGENERATIVE MEDICAL SOLUTIONS, INC. · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted
  2. US 10086114

    Antimicrobial solutions with enhanced stability

    The Board of Regents of the University of Texas System · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted
  3. US 10022367

    Sustained-release buprenorphine solutions

    Indivior UK Limited · Granted Jul 17, 2018 · Expires Jul 12, 2038

    granted
  4. US 9999634

    Dissolution stability of calcium carbonate tablets

    TAKEDA AS · Granted Jun 19, 2018 · Expires Jun 14, 2038

    granted
  5. US 9844530

    Ophthalmic solutions for glaucoma and conjunctivitis treatment

    AXIM BIOTECHNOLOGIES. INC. · Granted Dec 19, 2017 · Expires Dec 14, 2037

    granted
  6. US 9828634

    Markers for differentiation of stem cells into differentiated cell populations

    REGENERATIVE MEDICAL SOLUTIONS, INC. · Granted Nov 28, 2017 · Expires Nov 23, 2037

    granted
  7. US 9827215

    Solid solution compositions and use in chronic inflammation

    Infirst Healthcare Limited · Granted Nov 28, 2017 · Expires Nov 23, 2037

    granted
  8. US 9820952

    Solid solution compositions and use in chronic inflammation

    Infirst Healthcare Limited · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted
  9. US 9814695

    Ophthalmic solutions for glaucoma and conjunctivitis treatment

    AXIM BIOTECHNOLOGIES. INC. · Granted Nov 14, 2017 · Expires Nov 9, 2037

    granted
  10. US 9782430

    Resorbable oxidized cellulose embolization solution

    Covidien LP · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted
  11. US 9775820

    Solid solution compositions and use in chronic inflammation

    Infirst Healthcare Limited · Granted Oct 3, 2017 · Expires Sep 28, 2037

    granted
  12. US 9765302

    Compositions and methods for differentiating stem cells into cell populations comprising beta-like cells

    REGENERATIVE MEDICAL SOLUTIONS, INC. · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  13. US 9744132

    Solid solution compositions and use in chronic inflammation

    Infirst Healthcare Limited · Granted Aug 29, 2017 · Expires Aug 24, 2037

    granted
  14. US 9700509

    Solutions of lipophilic substances, especially medicinal solutions

    Universität Regensburg · Granted Jul 11, 2017 · Expires Jul 6, 2037

    granted
  15. US 9637597

    DOPA-melanin formation in high ionic strength solutions

    Northwestern University · Granted May 2, 2017 · Expires Apr 27, 2037

    granted
  16. US 9597302

    Combination of dofetilide and mexiletine for the prevention and treatment of atrial fibrillation

    Heart Rhythm Solutions, Inc. · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted
  17. US 9565857

    Antimicrobial solutions

    The Board of Regents of the University of Texas System · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted
  18. US 9539330

    Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy

    Jazz Pharmaceuticals, Inc. · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted
  19. US 9522963

    Dissolution of oxidized cellulose

    Covidien LP · Granted Dec 20, 2016 · Expires Dec 15, 2036

    granted
  20. US 9463195

    Dissolution of amyloid fibrils by flavonoids and other compounds

    The Regents of the University of California · Granted Oct 11, 2016 · Expires Oct 6, 2036

    granted
  21. US 9371516

    Compositions and methods for differentiating stem cells into cell populations comprising beta-like cells

    REGENERATIVE MEDICAL SOLUTIONS, INC. · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted
  22. US 9327031

    Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same

    United Therapeutics Corporation · Granted May 3, 2016 · Expires Apr 28, 2036

    granted
  23. US 9308213

    Solid solution compositions and use in chronic inflammation

    Infirst Healthcare Limited · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted
  24. US 9248113

    Infusion and injection solution of Levodopa

    Dizlin Medical Design AB · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted